Matching placebo for valbenazine clinical trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy

This study is looking into a new medicine called Valbenazine for adults with movement problems caused by cerebral palsy. It aims to see if the medicine helps reduce uncontrolled movements and if it's safe to use. Patients will be compared to others receiving a dummy medicine.